Previous 10 | Next 10 |
2023-10-16 05:30:00 ET Cathie Wood is known for buying tomorrow's potential success stories today, when their share prices may be in the doldrums and their products haven't yet reached the market -- or haven't reached their full potential. She gets in early at a great price, with the idea o...
2023-10-15 06:47:00 ET Investors looking for growth stocks that can make dramatic moves to the upside will find a couple of interesting options in the healthcare sector. CRISPR Therapeutics (NASDAQ: CRSP) and Ginkgo Bioworks (NYSE: DNA) have lost some ground in recent we...
2023-10-13 04:55:33 ET Summary CRISPR Therapeutics has upcoming catalysts and a strong cash position, making it a solid investment opportunity. The company's pipeline includes therapies for diabetes, immuno-oncology, and hemoglobinopathies, showcasing its diverse range of applicat...
2023-10-11 11:07:37 ET Summary Editas Medicine specializes in gene editing, targeting a range of serious illnesses, with a unique platform that covers over 95% of the human genome. EDIT's collaboration with Bristol-Myers Squibb aims to revolutionize cancer treatments, especially i...
2023-10-10 13:30:19 ET Summary I am returning from a break from writing articles to pursue the CFA designation, now I will focus on fixing my portfolio. The main issues with my portfolio are balance and the need for a review of current investments based on the 7 most important tre...
2023-10-10 05:30:00 ET Cathie Wood is known for seeking out the most innovative companies, placing big bets on them early, and holding on for the long term. This strategy has helped her flagship Ark Innovation ETF climb more than 25% to outperform the S&P 500 so far this year. A...
2023-10-02 10:00:00 ET If you've ever thought about investing in the gene-editing biotech space, Editas Medicine (NASDAQ: EDIT) and CRISPR Therapeutics (NASDAQ: CRSP) are doubtlessly familiar to you. While neither company is selling anything as of yet, in a few short months ...
2023-10-01 08:30:00 ET Despite the infamous market crashes in October of 1907, 1929, and 1987, October is actually one of the better months for stocks from a historical perspective. In fact, stocks tend to perk up at the start of the fourth quarter, making it one of the better-performing pe...
2023-09-29 07:49:11 ET More on Editas Editas Medicine, Inc. (EDIT) Cantor Global Healthcare Conference 2023 - (Transcript) Editas Medicine, Inc. (EDIT) CEO Gilmore O'Neill Presents at Morgan Stanley 21st Annual Global Healthcare Conference (Transcript) Editas Medicin...
2023-09-28 05:30:00 ET All three major indexes have rallied since the start of the year, and we're getting closer and closer to a new bull market. That's great news for growth stocks because they are often the ones to benefit in an optimistic environment that favors expansion. In fact, many...
News, Short Squeeze, Breakout and More Instantly...
CRISPR Therapeutics AG Company Name:
CRSP Stock Symbol:
NASDAQ Market:
CRISPR Therapeutics AG Website:
2024-07-17 10:10:00 ET July 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compan...